December 11, 2023 — A new deep learning challenge has been launched by the UEF Cancer AI research team, led by senior researcher Hamid Behravan, PhD, and funded by Sitra , the Finnish Innovation Fund. The challenge aims to develop an architecture capable of automatically estimating the breast percentage density from mammograms.

December 11, 2023 — RapidAI, a global leader in developing artificial intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, is proud

December 11, 2023 — Bracco Imaging S.p.A., an innovative world leader delivering end-to-end products and solutions through a comprehensive portfolio inclusive of precision diagnostic imaging modalities, announces that on December 7, 2023 the European Commission (EC) has granted the Marketing Authorisation for Vueway (

December 8, 2023 — Bering Limited, a London-based medical AI company, today announced it received U.S.

December 8, 2023 — Siemens Healthineers introduced the Acuson Maple¹, a powerful, versatile, and affordable ultrasound system that enables rapid diagnosis and assessment in all clinical settings. Artificial intelligence (AI)-powered features optimize everyday clinical performance for users of all skill levels.

December 7, 2023 — Royal Philips, a global leader in health technology, and Vanderbilt University Medical Center (VUMC), home to the top-ranked adult and pediatric hospitals in the Southeastern U.S., announced initial results of a research collaboration to decarbonize the health system’s radiology department.

December 6, 2023 — The American Medical Association (AMA) released new 

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today provided additional information regarding a March 2022 licensing and collaboration agreement between Philochem and Blue Earth Diagnostics.

Subscribe Now